Autor: "Schmidt, M." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.
Autorzy:: Keller M; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Rohlf K; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Glotzbach A; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Leonhardt G; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Lüke S; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Derksen K; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Demirci Ö; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Göçener D; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
AlWahsh M; Leibniz Institut Für Analytische Wissenschaften - ISAS E.V, Dortmund, Germany.; Institute of Pathology and Medical Research Center (ZMF), University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.; Department of Pharmacy, AlZaytoonah University of Jordan, Amman, Jordan.
Lambert J; Leibniz Institut Für Analytische Wissenschaften - ISAS E.V, Dortmund, Germany.
Lindskog C; Department of Immunology Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Schmidt M; Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany.
Brenner W; Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany.
Baumann M; Pharmacology Department, Lead Discovery Center, Dortmund, Germany.
Zent E; Pharmacology Department, Lead Discovery Center, Dortmund, Germany.
Zischinsky ML; Pharmacology Department, Lead Discovery Center, Dortmund, Germany.
Hellwig B; Department of Statistics, TU Dortmund University, Dortmund, Germany.
Madjar K; Department of Statistics, TU Dortmund University, Dortmund, Germany.
Rahnenführer J; Department of Statistics, TU Dortmund University, Dortmund, Germany.
Overbeck N; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Reinders J; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Cadenas C; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Hengstler JG; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Edlund K; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
Marchan R; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Jan 20; Vol. 42 (1), pp. 25. Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Humans ; Female ; Phosphatidylinositol 3-Kinases ; Cell Line, Tumor ; Choline/metabolism ; Choline/therapeutic use ; RNA, Small Interfering ; Receptor, ErbB-2/metabolism ; Drug Resistance, Neoplasm/genetics ; Phospholipases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Shared decision-making in routine breast cancer care in Germany-A cross-sectional study.
Autorzy:: Feiten S; Institut für Versorgungsforschung in der Onkologie, Koblenz, Germany.
Scholl I; Institut und Poliklinik für Medizinische Psychologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Dünnebacke J; Brustzentrum Marienhof, Katholisches Klinikum Koblenz-Montabaur, Koblenz, Germany.
Schmidt M; Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany.
Franzen A; Brustzentrum Kemperhof, Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany.
Ernst W; Brustzentrum St. Elisabeth, Gemeinschaftsklinikum Mittelrhein, Mayen, Germany.
Spaderna H; Abteilung Gesundheitspsychologie, Pflegewissenschaft, Universität Trier, Trier, Germany.
Weide R; Praxis für Hämatologie und Onkologie, Koblenz, Germany.; Pokaż więcej
Źródło:: Psycho-oncology [Psychooncology] 2022 Jul; Vol. 31 (7), pp. 1120-1126. Date of Electronic Publication: 2022 Feb 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/therapy
Decision Making, Shared*
Cross-Sectional Studies ; Decision Making ; Female ; Germany ; Humans ; Middle Aged ; Patient Participation ; Physician-Patient Relations

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Metronomic Chemotherapy for Metastatic Breast Cancer.
Autorzy:: Krajnak S; Department of Gynecology and Obstetrics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Battista MJ; Department of Gynecology and Obstetrics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Hasenburg A; Department of Gynecology and Obstetrics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Schmidt M; Department of Gynecology and Obstetrics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.; Pokaż więcej
Źródło:: Oncology research and treatment [Oncol Res Treat] 2022; Vol. 45 (1-2), pp. 12-17. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Antineoplastic Agents*/therapeutic use
Breast Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols ; Capecitabine/therapeutic use ; Cyclophosphamide/therapeutic use ; Female ; Humans ; Quality of Life ; Receptor, ErbB-2

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling - A SEER Analysis.
Autorzy:: Nahshon C; Department of Gynecological Oncology, Carmel Medical Center, Haifa, Israel.; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Segev Y; Department of Gynecological Oncology, Carmel Medical Center, Haifa, Israel.; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Schmidt M; Department of Gynecological Oncology, Carmel Medical Center, Haifa, Israel.; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Shulman K; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Department of Oncology, Lin and Carmel Medical Centers, Haifa, Israel.
Lavie O; Department of Gynecological Oncology, Carmel Medical Center, Haifa, Israel.; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Pokaż więcej
Źródło:: Oncology research and treatment [Oncol Res Treat] 2022; Vol. 45 (12), pp. 728-735. Date of Electronic Publication: 2022 Jun 15.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/epidemiology
Uterine Neoplasms*
Female ; Humans ; Risk

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: New Opportunities in Advanced Breast Cancer.
Autorzy:: Decker T; Oncology Ravensburg, Ravensburg, Germany, .
Schmidt M; Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany.; Pokaż więcej
Źródło:: Oncology research and treatment [Oncol Res Treat] 2022; Vol. 45 (1-2), pp. 1-3. Date of Electronic Publication: 2021 Dec 10.
Typ publikacji:: Editorial
MeSH Terms:: Breast Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols ; Female ; Humans ; Positron-Emission Tomography

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes.
Autorzy:: Heimes AS; Department of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Härtner F; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, 55131 Mainz, Germany.
Almstedt K; Department of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Krajnak S; Department of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Lebrecht A; Department of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Battista MJ; Department of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Edlund K; Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), 44139 Dortmund, Germany.
Brenner W; Department of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Hasenburg A; Department of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Sahin U; TRON-Translational Oncology at the University Medical Center Mainz, 55131 Mainz, Germany.
Gehrmann M; Bayer AG, 42113 Wuppertal, Germany.
Hengstler JG; Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), 44139 Dortmund, Germany.
Schmidt M; Department of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2020 Sep 29; Vol. 21 (19). Date of Electronic Publication: 2020 Sep 29.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor/*genetics
Breast Neoplasms/*genetics
Interferon-gamma/*genetics
Aged ; Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Staging ; Progression-Free Survival ; Receptor, ErbB-2/genetics ; Receptors, Estrogen/genetics ; Receptors, Progesterone/genetics ; Signal Transduction/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue.
Autorzy:: Hartmann K; BioNTech Diagnostics GmbH, An der Goldgrube 12, 55131, Mainz, Germany. .
Schlombs K; BioNTech Diagnostics GmbH, An der Goldgrube 12, 55131, Mainz, Germany.
Laible M; BioNTech Diagnostics GmbH, An der Goldgrube 12, 55131, Mainz, Germany.
Gürtler C; BioNTech Diagnostics GmbH, An der Goldgrube 12, 55131, Mainz, Germany.
Schmidt M; Department of Obstetrics and Gynecology, Johannes Gutenberg University, Langenbeckstraße 1, 55131, Mainz, Germany.
Sahin U; BioNTech AG, An der Goldgrube 12, 55131, Mainz, Germany.
Lehr HA; Institute of Pathology, Medizin Campus Bodensee, Röntgenstraße 2, 88048, Friedrichshafen, Germany.; Pokaż więcej
Źródło:: Diagnostic pathology [Diagn Pathol] 2018 Oct 20; Vol. 13 (1), pp. 83. Date of Electronic Publication: 2018 Oct 20.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Laser Capture Microdissection*
Real-Time Polymerase Chain Reaction*
Reverse Transcriptase Polymerase Chain Reaction*
Biomarkers, Tumor/*genetics
Breast Neoplasms/*genetics
Carcinoma/*genetics
Carcinoma, Intraductal, Noninfiltrating/*genetics
Gene Expression Profiling/*methods
RNA, Messenger/*genetics
Tissue Fixation/*methods
Breast Neoplasms/pathology ; Carcinoma/pathology ; Carcinoma, Intraductal, Noninfiltrating/pathology ; Estrogen Receptor alpha/genetics ; Female ; Fixatives ; Formaldehyde ; Humans ; Ki-67 Antigen/genetics ; Predictive Value of Tests ; Prognosis ; Receptor, ErbB-2/genetics ; Receptors, Progesterone/genetics ; Reproducibility of Results

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy.
Autorzy:: Hellwig B; Department of Statistics, TU Dortmund University, Dortmund, Germany.
Madjar K; Department of Statistics, TU Dortmund University, Dortmund, Germany.
Edlund K; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund University, Dortmund, Germany.
Marchan R; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund University, Dortmund, Germany.
Cadenas C; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund University, Dortmund, Germany.
Heimes AS; Department of Obstetrics and Gynaecology, University Hospital, Mainz, Germany.
Almstedt K; Department of Obstetrics and Gynaecology, University Hospital, Mainz, Germany.
Lebrecht A; Department of Obstetrics and Gynaecology, University Hospital, Mainz, Germany.
Sicking I; Department of Obstetrics and Gynaecology, University Hospital, Mainz, Germany.
Battista MJ; Department of Obstetrics and Gynaecology, University Hospital, Mainz, Germany.
Micke P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Schmidt M; Department of Obstetrics and Gynaecology, University Hospital, Mainz, Germany.
Hengstler JG; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund University, Dortmund, Germany.
Rahnenführer J; Department of Statistics, TU Dortmund University, Dortmund, Germany.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Dec 07; Vol. 11 (12), pp. e0167585. Date of Electronic Publication: 2016 Dec 07 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: Adaptor Proteins, Vesicular Transport/*genetics
Breast Neoplasms/*genetics
Carcinoma, Non-Small-Cell Lung/*genetics
Lung Neoplasms/*genetics
Neoplasm Metastasis/*genetics
Receptors, Estrogen/*genetics
Ribosomes/*genetics
Aged ; Antineoplastic Agents, Hormonal/therapeutic use ; Biomarkers, Tumor/genetics ; Breast Neoplasms/drug therapy ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Ribosomal Protein L3 ; Ribosomes/drug effects ; Tamoxifen/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints.
Autorzy:: Schmidt M; a International Society for Phytosciences , Mattsies , Germany .
Arjomand-Wölkart K; b Institut Für Pharmazeutische Wissenschaften, Karl-Franzens-Universität Graz , Graz , Austria .
Birkhäuser MH; c Gynaecological Endocrinonoly and Reproductive Medicine, Medical Faculty, University of Berne , Basel , Switzerland .
Genazzani AR; d Department of Gynaecology and Obstetrics , European Society of Gynecology, University of Pisa , Pisa , Italy .
Gruber DM; e 1st Department of Gynaeology and Obstetrics, University of Vienna , Wien , Austria .
Huber J; e 1st Department of Gynaeology and Obstetrics, University of Vienna , Wien , Austria .
Kölbl H; e 1st Department of Gynaeology and Obstetrics, University of Vienna , Wien , Austria .
Kreft S; f Chair of Pharmacognostic and Phytochemical Laboratory, Faculty of Pharmacy, University of Ljubljana , Ljubljana , Slovenia .
Leodolter S; e 1st Department of Gynaeology and Obstetrics, University of Vienna , Wien , Austria .
Linsberger D; e 1st Department of Gynaeology and Obstetrics, University of Vienna , Wien , Austria .
Metka M; e 1st Department of Gynaeology and Obstetrics, University of Vienna , Wien , Austria .
Simoncini T; g Division of Obstetrics and Gynadecology , Department of Clinical and Experimental Medicine, Università Di Pisa , Pisa , Italy , and.
Vrabic Dezman L; h Slovenian Menopause Society , Kranj , Slovenia.; Pokaż więcej
Źródło:: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology [Gynecol Endocrinol] 2016 Jun; Vol. 32 (6), pp. 427-30. Date of Electronic Publication: 2016 Mar 04.
Typ publikacji:: Journal Article
MeSH Terms:: Consensus*
Glycine max*
Breast Neoplasms/*prevention & control
Hot Flashes/*prevention & control
Isoflavones/*pharmacology
Menopause/*drug effects
Female ; Humans ; Isoflavones/administration & dosage ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Intrinsic Subtypes of Primary Breast Cancer--Gene Expression Analysis.
Autorzy:: Schmidt M; Department of Obstetrics and Gynecology, University Hospital, Mainz, Germany.
Thomssen C
Untch M; Pokaż więcej
Źródło:: Oncology research and treatment [Oncol Res Treat] 2016; Vol. 39 (3), pp. 102-10. Date of Electronic Publication: 2016 Feb 24.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Breast Neoplasms/*classification
Breast Neoplasms/*metabolism
Gene Expression Profiling/*methods
Neoplasm Proteins/*metabolism
Breast Neoplasms/pathology ; Female ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.
Autorzy:: Sharif GM; Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
Schmidt MO; Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
Yi C; Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
Hu Z; Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
Haddad BR; Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
Glasgow E; Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
Riegel AT; Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
Wellstein A; Lombardi Cancer Center, Georgetown University, Washington, DC, USA.; Pokaż więcej
Źródło:: Oncogene [Oncogene] 2015 Nov 26; Vol. 34 (48), pp. 5879-89. Date of Electronic Publication: 2015 Mar 16.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Cell Movement*
Gene Expression Regulation, Neoplastic*
Adaptor Proteins, Signal Transducing/*metabolism
Breast Neoplasms/*metabolism
Breast Neoplasms/*pathology
Endothelium, Vascular/*pathology
Phosphoproteins/*metabolism
Protein Serine-Threonine Kinases/*metabolism
Receptors, Interleukin-8B/*metabolism
Adaptor Proteins, Signal Transducing/genetics ; Animals ; Apoptosis ; Blotting, Western ; Breast Neoplasms/genetics ; Cell Cycle ; Cell Proliferation ; Cytokines/genetics ; Cytokines/metabolism ; Endothelium, Vascular/metabolism ; Female ; Human Umbilical Vein Endothelial Cells ; Humans ; Mice ; Mice, Nude ; Neoplasm Invasiveness ; Phosphoproteins/genetics ; Phosphorylation ; Protein Serine-Threonine Kinases/antagonists & inhibitors ; Protein Serine-Threonine Kinases/genetics ; RNA Interference ; RNA, Messenger/genetics ; Real-Time Polymerase Chain Reaction ; Receptors, Interleukin-8B/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Transcription Factors ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays ; YAP-Signaling Proteins ; Zebrafish

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
Autorzy:: Sicking I
Rommens K
Battista MJ
Böhm D
Gebhard S
Lebrecht A
Cotarelo C
Hoffmann G
Hengstler JG
Schmidt M; Department of Obstetrics and Gynecology, Johannes Gutenberg University, Mainz, Germany. marcus.schmidt@unimedizin-mainz.de.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2014 Dec 15; Vol. 14, pp. 952. Date of Electronic Publication: 2014 Dec 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*pathology
Cyclooxygenase 2/*genetics
Cyclooxygenase 2/*metabolism
Aged ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Female ; Gene Expression Profiling ; Humans ; Immunohistochemistry ; Middle Aged ; Oligonucleotide Array Sequence Analysis ; Prognosis ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/genetics ; Receptors, Progesterone/metabolism ; Survival Analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients.
Autorzy:: Sicking I; Department of Obstetrics and Gynecology, Johannes Gutenberg University, Mainz, Germany.
Edlund K; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund University of Technology, Dortmund, Germany.
Wesbuer E; Department of Obstetrics and Gynecology, Johannes Gutenberg University, Mainz, Germany.
Weyer V; Institute of Medical Biometry, Epidemiology and Informatics (IMBEI), Johannes Gutenberg University, Mainz, Germany.
Battista MJ; Department of Obstetrics and Gynecology, Johannes Gutenberg University, Mainz, Germany.
Lebrecht A; Department of Obstetrics and Gynecology, Johannes Gutenberg University, Mainz, Germany.
Solbach C; Department of Obstetrics and Gynecology, Johannes Gutenberg University, Mainz, Germany.
Grinberg M; Department of Statistics, Dortmund University of Technology, Dortmund, Germany.
Lotz J; Institute for Clinical Chemistry, Johannes Gutenberg University, Mainz, Germany.
Hoffmann G; Department of Obstetrics and Gynecology, Johannes Gutenberg University, Mainz, Germany.
Rahnenführer J; Department of Statistics, Dortmund University of Technology, Dortmund, Germany.
Hengstler JG; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund University of Technology, Dortmund, Germany.
Schmidt M; Department of Obstetrics and Gynecology, Johannes Gutenberg University, Mainz, Germany.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Oct 23; Vol. 9 (10), pp. e111306. Date of Electronic Publication: 2014 Oct 23 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*blood
C-Reactive Protein/*metabolism
Lymph Nodes/*pathology
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/mortality ; Breast Neoplasms/surgery ; Cell Proliferation ; Cohort Studies ; Disease-Free Survival ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Genome, Human ; Humans ; Inflammation/metabolism ; Ki-67 Antigen/metabolism ; Middle Aged ; Neoplasm Metastasis ; Prognosis ; Proportional Hazards Models ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ.
Autorzy:: Ory V; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Tassi E; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Cavalli LR; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Sharif GM; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Saenz F; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Baker T; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Schmidt MO; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Mueller SC; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Furth PA; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Wellstein A; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Riegel AT; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.; Pokaż więcej
Źródło:: Oncogene [Oncogene] 2014 Jun 05; Vol. 33 (23), pp. 3033-42. Date of Electronic Publication: 2013 Jul 15.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Breast Neoplasms/*metabolism
Breast Neoplasms/*pathology
Carcinoma, Intraductal, Noninfiltrating/*metabolism
Carcinoma, Intraductal, Noninfiltrating/*pathology
Neoplastic Stem Cells/*physiology
Nuclear Receptor Coactivator 3/*metabolism
Animals ; Cell Differentiation/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Mammary Neoplasms, Experimental ; Mice ; Mice, Nude ; Neoplastic Stem Cells/pathology ; Nuclear Receptor Coactivator 3/antagonists & inhibitors ; Nuclear Receptor Coactivator 3/genetics ; RNA, Small Interfering/pharmacology ; Signal Transduction/genetics ; Xenograft Model Antitumor Assays